¡Ya estamos en ! Descubre más

Avantor

AVTR

Capitalización de mercado USD 11.1 mil M

16.42 USD

+0.33

2.05%

Al cierre Actualizado 16 oct, 4:00 p.m. EDT

Antes de la apertura del mercado

Después del cierre del mercado

16.44

+0.02

0.12%

1 día

2.05%

5 días

4.52%

1 mes

5.19%

3 meses

45.83%

6 meses

98.79%

En lo que va del año

43.28%

1 año

12.7%

5 años

-57.42%

10 años

13.24%

Acerca de: Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.

Empleados: 13,500

Atención médica Instrumentos y suministros médicos

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 65.2%

Neutral 26.1%

Negativo 8.7%

Longleaf Partners Fund Q3 2026 Portfolio Review

The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.

Longleaf Partners Fund Q3 2026 Portfolio Review

Zacks Investment Research

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

AVTR's improving commercial execution, specialty product strength and raised 2026 outlook signal recovery potential despite lingering demand challenges.

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

Zacks Investment Research

VTRS vs. AVTR: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Viatris (VTRS) or Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?

VTRS vs. AVTR: Which Stock Is the Better Value Option?

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

RADNOR, Pa., Oct. 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, and will hold a related conference call on the same day at 8:00 a.m.

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

Zacks Investment Research

Are Medical Stocks Lagging Avantor (AVTR) This Year?

Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Avantor (AVTR) This Year?

Avantor appoints new Chief Financial Officer

RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026.

Avantor appoints new Chief Financial Officer

Zacks Investment Research

Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC

AVTR expands its RIM single-use bioprocessing portfolio across APAC, boosting access to locally made solutions and supporting its bioprocessing growth push.

Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC

Zacks Investment Research

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

Zacks Investment Research

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?

Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?

Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?

Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™